SCHEMBL19804373

SCHEMBL19804373

C=C(C)C(=O)OCCCc1cc(-c2ccc(-c3ccccc3F)cc2)ccc1OCCO

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 3/20 0.42
PPARG P37231 1/20 0.38
LTB4R Q15722 3/20 0.37
CYP2C9 P11712 1/20 0.37
LTB4R2 Q9NPC1 2/20 0.37
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
MTNR1B P49286 2/20 0.36
POLB P06746 1/20 0.35
APEX1 P27695 1/20 0.35
HTT P42858 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
RARA P10276 2/20 0.35
RARB P10826 2/20 0.35
RARG P13631 2/20 0.35
HIF1A Q16665 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PDE4A P27815 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19804354 0.91 ALOX5AP (0.41) SLC6A9LTB4RLTB4R2ALOX5APFEN1
SCHEMBL19804515 0.90 SLC6A9 (0.43) SLC6A9PPARGMTNR1BPOLBAPEX1
SCHEMBL19804047 0.89 SLC6A9 (0.36) SLC6A9PPARGLTB4RPOLBAPEX1
SCHEMBL19804318 0.89 SLC6A9 (0.36) SLC6A9PPARGPOLBAPEX1HTT
SCHEMBL19804276 0.88 ALDH1A1 (0.36) SLC6A9PPARGLTB4RPOLBAPEX1
SCHEMBL22173817 0.86 POLB (0.39) MTNR1BPOLBAPEX1HTTTDP1
SCHEMBL19804398 0.85 ALOX5AP (0.42) SLC6A9LTB4RLTB4R2ALOX5APFEN1
SCHEMBL19804416 0.85 POLB (0.42) SLC6A9LTB4RMTNR1BPOLBAPEX1
SCHEMBL19804132 0.85 PPARD (0.38) PPARGLTB4RLTB4R2ALOX5APFEN1
SCHEMBL19804516 0.85 RARB (0.43) SLC6A9PPARGLTB4RLTB4R2MTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 SLC6A9 2938/4885PPARG 3314/4885LTB4R 2415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.